This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
C3_BONE_CARTILAGE_NAS
bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
235 |
4. Check minimum number of eventsNone |
235 |
5. Include endpointsNone |
235 |
6. Filter based on genotype QC (FinnGen only) |
203 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bone and articular cartilage
- Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo
- Malignant neoplasm of bone and articular cartilage, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 203 | 92 | 111 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 61.12 | 59.68 | 62.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 208
- Matched controls
- 2080
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
94.1
83
*
JN4AD
NOMESCO Finland
Body CT examination
21.3
90.4
79
58
XX3DW
NOMESCO Finland
Time consuming IT work
24.0
87.2
70
43
H02AB02
ATC
dexamethasone; systemic
268.3
85.4
82
5
XW000
NOMESCO Finland
Bone marrow biopsy
44.1
85.3
53
16
JN4BD
NOMESCO Finland
Extensive body CT
22.5
81.5
67
43
A04AA01
ATC
ondansetron; systemic, rectal
30.6
75.7
53
23
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
149.3
61.9
63
6
130
Kela drug reimbursment
Malignant tumour
+∞
59.2
54
*
N02AA05
ATC
oxycodone; systemic
9.4
57.1
97
177
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
51.2
47
*
L03AA02
ATC
filgrastim; parenteral
581.6
48.4
46
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.3
46.4
80
145
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
45.5
42
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
45.5
42
*
WZC00
NOMESCO Finland
Treatment plan or consultation
7.2
45.3
130
391
C90.0
ICD-10 Finland
Multiple myeloma
+∞
43.2
40
*
WF002
NOMESCO Finland
Radical radiotherapy
238.5
39.3
39
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
16.9
37.3
33
23
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
427.5
37.2
36
*
A04AA02
ATC
granisetron; systemic, transdermal
427.5
37.2
36
*
Z51.5
ICD-10 Finland
Palliative care
12.1
36.6
40
40
L03AA13
ATC
pegfilgrastim; parenteral
379.3
32.8
32
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
32.1
30
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.6
30.0
39
49
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
29.9
28
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
336.5
29.6
29
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
26.6
25
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
33.5
26.4
34
12
WZC30
NOMESCO Finland
Teaching
5.6
26.2
63
151
153
Kela drug reimbursment
Lenalidomid
+∞
25.5
24
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
25.5
24
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
25.5
24
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
28.7
25.3
34
14
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
23.5
73
215
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.6
23.2
32
43
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
22.6
145
715
N03AX16
ATC
[U] pregabalin
4.3
22.6
87
300
B01AB05
ATC
enoxaparin; parenteral
4.1
22.6
101
388
WX402
NOMESCO Finland
General anaesthesia
4.5
22.5
76
238
B01AB10
ATC
tinzaparin; parenteral
6.1
22.3
44
87
L04AX04
ATC
lenalidomide; oral
+∞
22.3
21
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
22.3
21
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
22.3
21
*
C41.49
ICD-10 Finland
Malignant tumor of the pelvic bones, sacrum and coccyx other or unspecified histology
+∞
22.3
21
*
329
Kela drug reimbursment
Lenalidomide
+∞
22.3
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.2
21.5
84
291
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
9.5
21.5
27
32
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
21.2
20
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
21.2
20
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.4
20.9
48
109
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
20.1
19
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.1
19.6
32
52
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.6
18.7
40
85
JN4CD
NOMESCO Finland
Very extensive body CT
25.6
18.2
25
11
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
18.0
17
*
WW500
NOMESCO Finland
Blood transfusion
16.8
17.7
28
19
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.7
17.2
46
118
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
16.9
16
*
C41.4
ICD-10 Finland
Malignant neoplasm: Pelvic bones, sacrum and coccyx
+∞
16.9
16
*
R4110
NOMESCO Finland
Physiotherapy
3.5
16.7
89
370
ZX120
NOMESCO Finland
Intravenous
5.9
16.4
32
62
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.8
15
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
15.8
15
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.5
14.8
31
64
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
14.8
14
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
14.8
14
*
9370/3-C41.4
ICD-O-3
Chordoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
14.8
14
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
14.8
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
14.8
14
*
GD1AD
NOMESCO Finland
Thorax CT examination
5.8
14.4
28
54
J05AB01
ATC
aciclovir; systemic
3.4
14.3
68
260
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.8
13.7
24
21
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
13.7
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
13.7
42
119
ZX090
NOMESCO Finland
Other technic of radiotherapy
149.3
13.6
14
*
N02BF02
ATC
pregabalin; oral
5.2
13.5
30
65
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.1
13.3
30
66
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
14.3
13.3
22
17
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
12.6
12
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
12.6
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
12.6
12
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
12.6
12
*
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
12.6
12
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
+∞
12.6
12
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
12.6
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
12.6
12
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
12.6
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
138.0
12.6
13
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
40.1
12.4
15
*
R50.9
ICD-10 Finland
Fever, unspecified
3.5
12.2
50
172
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.6
12.1
24
47
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
12.0
88
425
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
32.1
11.8
15
5
M04AA01
ATC
allopurinol; systemic
3.5
11.8
49
170
M05BX04
ATC
denosumab; parenteral
5.3
11.8
25
52
NK6AN
NOMESCO Finland
Total body bone isotope imaging
69.0
11.7
13
*
WZC15, ,
NOMESCO Finland
+∞
11.6
11
*
C41.3
ICD-10 Finland
Malignant neoplasm: Ribs, sternum and clavicle
+∞
11.6
11
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
11.6
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.6
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
11.6
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.6
11
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
11.6
11
*
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
11.6
11
*
C41.40
ICD-10 Finland
Pelvic bones, sacrum and coccyx
+∞
11.6
11
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.6
11
*
A06AH03
ATC
naloxegol; oral
126.7
11.5
12
*
JN6AD
NOMESCO Finland
CT of torso and neck
26.8
11.3
15
6
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
26.8
11.3
15
6
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.7
11.2
28
67
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.9
10.9
18
14
TPX10
NOMESCO Finland
Implantation of vascular injection port
15.3
10.7
17
12
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.9
10.6
20
37
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
+∞
10.5
10
*
9680/3-C41.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of vertebral column
+∞
10.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
+∞
10.5
10
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.4
10.3
21
42
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.6
9.9
37
119
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.1
9.8
20
24
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
57.8
9.7
11
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
57.8
9.7
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.4
9.4
20
26
H02AB09
ATC
hydrocortisone; systemic
12.3
9.2
16
14
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.8
9.2
17
17
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
9.2
39
136
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
8.9
40
144
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
28.9
8.6
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
8.4
39
143
9731/3-C41.4
ICD-O-3
Plasmacytoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
8.4
8
*
C41.2
ICD-10 Finland
Malignant neoplasm: Vertebral column
+∞
8.4
8
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
8.4
8
*
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
8.4
8
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
8.4
8
*
C41.20
ICD-10 Finland
Malignant tumor of the spine without histology
+∞
8.4
8
*
D16.8
ICD-10 Finland
Benign neoplasm: Pelvic bones, sacrum and coccyx
+∞
8.4
8
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
8.4
8
*
WW409
NOMESCO Finland
Other aferesis
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
HA1AA
NOMESCO Finland
X-ray mammography
7.4
8.3
19
28
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
9.5
8.2
16
18
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
34.8
8.2
10
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.0
8.0
18
39
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
8.0
85
473
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.2
7.9
22
57
ZXE40
NOMESCO Finland
More than seven and less than nine hours
15.8
7.8
12
8
ZX112
NOMESCO Finland
Subcutaneous
15.8
7.8
12
8
AA1AA
NOMESCO Finland
Head X-ray examination
19.3
7.7
11
6
A02BC02
ATC
pantoprazole; systemic
2.5
7.5
155
1130
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
7.4
34
124
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
7.3
7
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
C41.06
ICD-10 Finland
Chondrosarcoma of the skull or facial bones except maxilla
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
7.3
7
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
C41.29
ICD-10 Finland
Malignant tumor of the spine other or unspecified histology
+∞
7.3
7
*
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
+∞
7.3
7
*
C41.82
ICD-10 Finland
Overall chondrosarcoma in bone and articular cartilage
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
C41.41
ICD-10 Finland
Osteosarcoma of the pelvic bones, sacrum and coccyx
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
7.3
7
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
7.3
36
137
L02BG04
ATC
letrozole; oral
31.2
7.2
9
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
12.6
7.2
12
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
7.1
48
215
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
7.1
104
652
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.2
7.0
102
637
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
41.4
6.8
8
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
41.4
6.8
8
*
B01AB04
ATC
dalteparin; parenteral
5.9
6.8
18
33
ZXD05
NOMESCO Finland
Urgent procedure
2.2
6.8
74
411
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.3
6.7
14
18
XX2RW, ,
NOMESCO Finland
23.4
6.7
9
*
N02BE01
ATC
paracetamol; systemic, rectal
4.0
6.6
194
1618
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
6.6
44
196
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
14.9
6.5
10
7
ZX108
NOMESCO Finland
Inhalation
72.0
6.5
7
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
72.0
6.5
7
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
18.7
6.3
9
5
J01MA12
ATC
levofloxacin; systemic
2.5
6.3
44
200
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
9101
FHL
Bone biopsy
+∞
6.3
6
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
6.3
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.3
6
*
C41.09
ICD-10 Finland
Malignant tumor of the skull or facial bones other or unspecified histology
+∞
6.3
6
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
6.3
6
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
6.3
6
*
C41.0
ICD-10 Finland
Malignant neoplasm: Bones of skull and face
+∞
6.3
6
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
6.3
6
*
9731/3-C41.9
ICD-O-3
Plasmacytoma, NOS, of bone, NOS
+∞
6.3
6
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
+∞
6.3
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
N07BC02
ATC
methadone; systemic
+∞
6.3
6
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.1
6.1
14
21
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.0
6.1
12
14
ZXE00
NOMESCO Finland
One hour or less
2.1
6.1
86
524
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
66
59
15.92
66.50
13.4
1.3
35.06
43.02
mg/l
0.51
60
52
66
59
15.92
66.50
13.3
1.3
34.66
29.58
mg/l
0.12
60
52
62
54
15.93
63.28
11.7
1.3
4.66
1.29
ratio
0.60
45
30
97
166
10.08
60.80
8.2
2.3
224.24
233.62
u/l
0.46
97
159
88
268
4.96
27.72
5.6
3.2
0.81
0.83
mmol/l
0.69
88
251
81
244
4.80
25.59
7.1
6.2
1.04
1.07
mmol/l
0.37
81
227
170
908
5.77
24.68
16.0
4.0
9.84
12.18
umol/l
3.03
165
859
174
967
5.89
23.47
25.9
6.5
4.37
4.21
e9/l
0.15
161
834
151
767
4.53
22.59
4.6
2.4
—
—
estimate
—
0
0
152
806
4.29
20.65
16.2
6.1
1.20
1.21
mmol/l
0.22
147
730
99
404
3.77
19.72
4.1
2.0
—
—
—
0
0
161
906
4.44
19.68
20.4
6.1
1.20
1.21
mmol/l
0.61
144
790
37
76
5.71
17.87
9.0
1.2
1.31
0.40
g/l
0.59
27
69
78
294
3.64
17.13
2.2
1.7
—
—
—
0
0
64
215
3.86
16.63
10.6
8.1
1.28
1.20
mmol/l
0.06
51
184
105
484
3.36
16.63
4.4
2.4
311.52
359.82
umol/l
5.07
99
418
41
99
4.91
16.45
5.9
1.8
5.94
2.57
ug/l
1.10
32
73
111
557
3.13
14.77
9.7
2.0
2.35
2.36
mmol/l
0.18
104
493
25
43
6.47
14.36
1.8
1.3
—
—
—
0
0
167
1081
3.76
14.03
10.3
4.7
6.67
6.79
mmol/l
0.39
161
1029
58
223
3.22
11.84
2.0
1.6
—
—
—
0
0
39
116
3.91
11.79
14.1
9.5
25.01
24.84
mmol/l
0.11
39
116
46
154
3.55
11.70
4.5
3.2
—
—
—
0
0
22
41
5.88
11.62
2.0
1.5
—
—
—
0
0
16
8
21.52
11.32
1.8
3.5
—
—
—
0
0
16
9
19.11
10.91
1.6
2.9
16.94
10.11
%
—
16
9
54
210
3.12
10.73
2.0
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
49
5.15
10.52
2.1
3.5
0.35
0.42
iu/ml
0.31
12
27
19
36
5.71
9.84
1.6
1.2
—
—
—
0
0
94
518
2.49
9.31
4.0
3.1
1.00
0.27
e6/l
0.50
73
362
25
65
4.23
8.99
8.8
1.2
0.00
0.00
g/l
-0.00
17
59
16
16
10.73
8.69
3.8
1.9
413.81
849.13
mg
0.74
16
16
25
68
4.04
8.46
8.5
1.2
0.00
0.00
g/l
-0.00
18
63
36
132
3.09
7.77
2.5
1.9
71.76
65.17
ml/min/173m2
0.48
21
48
18
42
4.60
7.38
2.1
1.4
10.74
6.57
u/l
0.47
12
36
16
22
7.78
7.34
1.7
1.2
—
—
—
0
0
7
0
+∞
7.33
2.6
0.0
18.57
—
u/ml
—
7
0
18
43
4.49
7.17
2.2
2.1
24.56
16.13
u/ml
0.36
18
30
33
121
3.05
7.10
2.5
1.5
—
—
—
0
0
16
24
7.13
6.96
4.3
4.5
10.48
11.74
mg/l
0.47
16
24
21
58
3.91
6.95
6.7
7.7
1.31
1.54
mg/l
0.56
21
52
32
118
3.02
6.81
17.0
11.3
0.65
0.65
%
0.01
32
118
30
109
3.05
6.55
1.9
1.4
—
—
—
0
0
18
35
5.53
6.49
1.6
1.2
—
—
—
0
0
13
16
8.58
6.43
1.3
1.3
—
—
—
0
0
13
16
8.58
6.43
3.5
1.4
33.00
32.56
pg
0.12
13
16
44
198
2.55
6.43
2.9
2.3
5.59
5.52
umol/l
0.04
39
183
53
261
2.38
6.38
10.4
6.2
104.06
104.28
mmol/l
0.11
53
261
32
123
2.89
6.33
17.0
11.0
1.38
1.43
%
0.11
32
123
9
6
15.59
5.96
2.7
2.2
—
—
—
0
0
12
15
8.41
5.92
1.6
1.2
—
—
—
0
0
111
757
2.00
5.66
4.5
4.0
29.88
39.78
ng/l
0.71
93
558
32
131
2.71
5.62
1.9
2.3
0.20
0.20
g/l
0.03
32
117
5
0
+∞
5.23
1.0
0.0
—
—
—
0
0
5
0
+∞
5.23
4.6
0.0
—
—
—
0
0
77
479
1.96
4.97
2.1
2.1
2.44
2.63
mg/l
0.46
68
415
8
8
10.34
4.56
2.5
1.6
3.26
5.05
nmol/l
—
8
8
54
307
2.03
4.43
4.1
3.0
3.54
1.99
e6/l
0.48
31
143
15
45
3.51
4.41
4.1
2.7
89.80
94.44
%
0.34
15
45
10
16
6.50
4.35
1.7
1.3
—
—
—
0
0
8
9
9.19
4.32
5.1
1.0
43.46
40.57
g/l
—
8
9
77
498
1.87
4.31
5.7
3.9
0.00
0.00
estimate
-0.00
30
153
57
335
1.97
4.25
3.4
2.9
0.79
0.82
e6/l
0.04
32
170
25
107
2.52
4.01
2.8
1.4
—
—
—
0
0
197
1757
3.29
3.99
42.0
13.6
30.58
24.51
mg/l
1.66
184
1416
61
374
1.89
3.99
3.8
1.7
0.88
0.98
mg/l
0.31
50
288
88
613
1.75
3.75
5.2
3.4
1074.76
1297.08
ng/l
0.34
83
518
14
45
3.26
3.72
1.9
1.2
—
—
—
0
0
9
16
5.82
3.70
1.0
1.0
—
—
—
0
0
11
27
4.24
3.45
1.7
1.1
—
—
—
0
0
13
42
3.23
3.43
1.6
1.1
—
—
—
0
0
13
38
3.58
3.38
1.4
1.8
—
—
—
0
0
8
14
5.89
3.37
1.6
1.1
—
—
—
0
0
132
1049
1.71
3.35
2.8
2.8
—
—
—
0
0
6
7
8.78
3.28
2.2
1.0
—
—
—
0
0
33
174
2.07
3.28
3.9
1.8
375.85
381.91
nmol/l
0.07
33
164
12
34
3.68
3.25
1.7
1.1
—
—
—
0
0
8
15
5.50
3.22
1.9
2.1
—
—
—
0
0
12
35
3.57
3.16
1.4
1.3
—
—
—
0
0
190
1701
2.35
3.14
38.1
13.2
81.76
79.54
ml/min/173m2
0.66
176
1549
7
12
5.99
3.04
4.0
1.2
—
—
—
0
0
5
5
10.20
2.99
2.4
1.0
—
—
—
0
0
8
17
4.85
2.95
1.3
1.1
—
—
—
0
0
8
17
4.85
2.95
1.3
1.1
—
—
—
0
0
15
58
2.71
2.94
2.4
3.9
—
—
—
0
0
7
13
5.53
2.89
1.6
1.1
—
—
—
0
0
7
13
5.53
2.89
1.6
1.1
—
—
—
0
0
7
13
5.53
2.89
1.6
1.1
—
—
—
0
0
6
9
6.82
2.88
1.8
1.3
—
—
—
0
0
11
33
3.46
2.86
1.8
1.2
—
—
—
0
0
11
33
3.46
2.86
1.6
1.0
—
—
—
0
0
11
33
3.46
2.86
1.8
1.2
—
—
—
0
0
5
6
8.50
2.76
2.4
1.0
—
—
—
0
0
16
68
2.47
2.63
2.4
1.5
—
—
—
0
0
7
15
4.79
2.62
1.3
1.1
—
—
—
0
0
10
32
3.23
2.47
2.1
5.2
8.60
10.15
pmol/l
—
10
32
117
949
1.53
2.37
5.8
3.8
0.00
0.00
estimate
-0.00
32
163
15
66
2.37
2.30
2.1
1.5
—
—
—
0
0
117
960
1.50
2.17
5.9
3.8
0.00
0.00
estimate
-0.00
32
163
92
720
1.50
2.14
6.3
3.7
0.06
0.01
estimate
0.41
31
131
5
10
5.09
2.08
1.2
1.8
10.00
13.50
umol/l
—
5
10
47
324
1.58
1.93
1.7
1.6
1500.11
1153.52
nmol/l
1.05
36
247
12
52
2.39
1.91
1.2
1.3
—
—
—
0
0
116
969
1.45
1.85
5.8
3.8
0.00
0.03
estimate
0.50
31
151
6
18
3.40
1.76
1.5
1.3
—
—
—
0
0
11
48
2.36
1.73
1.3
1.3
334.60
301.82
ug/g
—
5
26
5
13
3.91
1.72
1.0
1.2
63.60
84.92
pmol/l
—
5
13
13
62
2.17
1.69
1.3
1.2
—
—
—
0
0
7
25
2.86
1.66
1.0
1.4
—
—
—
0
0
13
63
2.13
1.63
1.3
1.2
—
—
—
0
0
5
14
3.63
1.62
1.0
9.7
—
38.50
—
0
6
6
20
3.06
1.59
1.3
1.2
—
—
—
0
0
7
155
0.43
1.50
1.6
2.2
3.54
3.48
ratio
—
7
129
6
23
2.65
1.37
1.0
1.2
—
—
—
0
0
5
17
2.99
1.36
1.0
1.0
—
—
—
0
0
8
34
2.41
1.30
1.1
1.4
—
—
—
0
0
16
93
1.78
1.25
1.3
1.3
—
—
—
0
0
133
1185
1.34
1.21
3.2
3.2
57.12
47.85
u/l
0.50
128
1111
63
506
1.35
1.16
6.0
3.3
0.00
0.00
estimate
-0.00
30
128
5
21
2.41
1.09
1.0
1.8
3.16
179.03
u/ml
—
5
21
200
1936
1.86
0.97
58.0
20.8
4.21
4.54
e12/l
11.39
194
1891
200
1936
1.86
0.97
58.1
20.8
246.10
244.82
e9/l
0.09
194
1898
164
1736
0.74
0.96
6.2
6.8
38.55
39.93
mmol/mol
1.53
153
1628
9
154
0.57
0.93
1.2
1.5
—
—
—
0
0
101
889
1.26
0.91
2.0
2.1
87.08
96.94
pmol/l
1.12
61
450
70
813
0.79
0.84
1.9
2.0
1.46
1.31
mmol/l
0.62
58
691
10
58
1.76
0.81
1.9
1.5
—
—
—
0
0
18
123
1.51
0.80
1.4
1.2
840.83
290.81
u/ml
0.33
18
113
17
116
1.51
0.77
6.5
2.7
0.54
0.61
%
0.47
17
116
24
176
1.41
0.77
2.4
1.9
45.60
36.01
u/l
0.24
15
144
149
1390
1.25
0.74
4.5
4.0
14.95
14.93
pmol/l
0.03
136
1266
29
222
1.36
0.73
6.8
7.2
—
—
—
0
0
17
118
1.48
0.72
6.5
2.8
1.21
1.21
%
0.00
17
118
46
381
1.27
0.67
1.6
1.8
438.26
36908950.39
pmol/l
0.50
34
317
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
46
387
1.24
0.59
3.7
3.8
49.28
427.52
ng/l
2.15
36
310
53
456
1.22
0.56
5.6
3.8
1.02
1.02
kg/l
0.90
39
305
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
80
733
1.15
0.40
4.7
4.1
3.65
1.84
ug/l
0.61
73
654
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
34
296
1.18
0.33
1.3
1.6
—
—
—
0
0
177
1811
0.85
0.31
4.8
6.2
2.55
2.62
mmol/l
0.56
165
1683
7
54
1.31
0.30
2.3
1.2
—
—
—
0
0
30
342
0.86
0.29
1.2
1.3
21.41
34.24
iu/ml
—
7
97
65
701
0.89
0.28
3.2
4.1
13.61
7.39
mg/mmol
0.49
37
445
6
81
0.73
0.24
1.5
2.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
49.40
—
0
13
172
1686
1.12
0.20
3.8
4.5
1.30
1.28
mmol/l
0.14
160
1550
41
444
0.90
0.19
1.3
1.4
1.79
1.07
u/ml
0.40
17
121
175
1780
0.89
0.19
4.4
5.4
4.39
4.52
mmol/l
0.96
161
1657
6
52
1.16
0.19
1.5
1.6
—
—
—
0
0
23
204
1.14
0.19
1.5
1.4
—
—
—
0
0
19
167
1.15
0.17
4.7
2.5
0.43
0.32
e6/l
0.20
19
161
14
162
0.85
0.17
1.3
2.2
—
—
—
0
0
175
1777
0.90
0.16
4.3
5.3
1.34
1.46
mmol/l
3.34
160
1646
8
95
0.84
0.14
1.0
1.0
—
—
—
0
0
45
426
1.07
0.12
2.8
2.7
0.98
0.72
ug/l
0.54
31
266
13
147
0.88
0.12
1.2
2.0
—
—
—
0
0
29
310
0.93
0.10
1.3
1.3
68.51
9.02
u/ml
—
7
123
170
1679
1.07
0.10
5.7
5.0
1.88
1.91
mu/l
0.15
158
1539
26
242
1.09
0.10
4.7
4.9
31.00
32.45
%
0.38
19
150
6
57
1.05
0.08
1.5
1.3
—
—
—
0
0
20
185
1.09
0.08
1.8
2.7
6.01
7.54
ug/l
0.30
20
164
177
1756
1.05
0.06
4.8
5.3
5.90
6.02
mmol/l
0.73
159
1604
59
581
1.02
0.02
4.3
3.8
22.67
24.47
%
0.38
27
264
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
7.65
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
7.6
—
10.86
—
0
5
6
69
0.87
-0.00
1.5
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.18
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.6
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
6.87
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
13.99
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BONE_CARTILAGE_NAS – Malignant neoplasm of bone and articular cartilage of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).